<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02059291</url>
  </required_header>
  <id_info>
    <org_study_id>CACZ885N2301</org_study_id>
    <nct_id>NCT02059291</nct_id>
  </id_info>
  <brief_title>Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers</brief_title>
  <official_title>A Randomized, Double-blind, Placebo Controlled Study of Canakinumab in Patients With Hereditary Periodic Fevers (TRAPS, HIDS, or crFMF), With Subsequent Randomized Withdrawal/Dosing Frequency Reduction and Open-label Long-term Treatment Epochs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to determine whether canakinumab is able to induce and maintain a clinically
      meaningful reduction of disease activity in participants with Hereditary Periodic Fevers
      (HPF) compared to placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study consists of 3 randomized cohorts (one per condition of colchicine
      resistant/intolerant Familial Mediterranean Fever (crFMF), Hyper Immunoglobulin D Syndrome
      (also known as mevalonate kinase deficiency (HIDS/MKD), and Tumor Necrosis Factor Receptor
      Associated Periodic Syndrome (TRAPS), and 4 study epochs:

        1. Epoch 1: a screening epoch to assess participant's eligibility;

        2. Epoch 2: a randomized treatment epoch of 16 weeks where participants are randomized to
           canakinumab 150 mg every 4 weeks (q4w) or to placebo to obtain efficacy and safety data
           in a double-blind placebo controlled parallel-arm setting. This epoch contained 2
           possible escape options :

             1. early blinded escape option for non responders from Day 8 to Day 28 with here an
                add-on dose of 150mg canakinumab followed by blinded uptitration at the next
                scheduled visit (Day 29)

             2. late unblinded escape option for non responders from Day 29 to Day 112; with
                open-label uptitration

        3. Epoch 3: a randomized withdrawal epoch of 24 weeks where canakinumab responders from the
           randomized treatment epoch were re-randomized to canakinumab 150mg q8w or placebo to
           assess the potential for canakinumab to maintain clinical efficacy at a reduced dosing
           frequency;

        4. Epoch 4: an open-label treatment epoch of 72 weeks to collect long-term
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 27, 2014</start_date>
  <completion_date type="Actual">July 4, 2017</completion_date>
  <primary_completion_date type="Actual">July 4, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants With Resolution of Initial Flare and Absence of New Flares up to the End of the Randomized Treatment Epoch (16 Weeks)</measure>
    <time_frame>16 weeks</time_frame>
    <description>Resolution of the initial disease flare is defined as: Physician's Global Assessment of Disease activity (PGA) &lt;2 and C-reactive protein (CRP) within normal range (&lt;= 10 mg/L) or reduction by at least 70% from baseline. The PGA was evaluated by the investigator based on a 5-point scale: 0 = None (no) disease associated with clinical signs and symptoms; 1 = minimal disease associated signs and symptoms; 2 = mild disease associated signs and symptoms; 3 = moderate disease associated signs and symptoms; and 5 = severe disease associated signs and symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Achieve Physician's Global Assessment (PGA) &lt; 2</measure>
    <time_frame>16 weeks</time_frame>
    <description>The PGA was evaluated by the investigator based on a 5-point scale: 0 = None (no) disease associated with clinical signs and symptoms; 1 = minimal disease associated signs and symptoms; 2 = mild disease associated signs and symptoms; 3 = moderate disease associated signs and symptoms; and 5 = severe disease associated signs and symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With the Serologic Remission</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serologic remission was defined as C-reactive protein &lt;= 10 mg/L.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Normalized Serum Amyloid A (SAA) Level</measure>
    <time_frame>16 weeks</time_frame>
    <description>Normalized SAA was defined as SAA &lt;= 10 mg/L.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants of Canakinumab Responders From Epoch 2 Who Maintained a Clinically Meaningful Response (Absence of New Flares) (40 Weeks)</measure>
    <time_frame>40 weeks</time_frame>
    <description>A responder was defined as a participant who had no flare between week 16 and week 40.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">203</enrollment>
  <condition>Hereditary Periodic Fevers</condition>
  <arm_group>
    <arm_group_label>crFMF: 150 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>crCMF: placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>During epoch 2, participants received matching placebo to canakinumab 150 mg Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab.
150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIDS/MKD: 150 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIDS/MKD: placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRAPS: 150 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRAPS: placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between Day 8 and 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Canakinumab</intervention_name>
    <description>Canakinumab solution for subcutaneous injection in vial which contained 150mg/mL canakinumab in 1 mL solution.</description>
    <arm_group_label>crFMF: 150 mg</arm_group_label>
    <arm_group_label>HIDS/MKD: 150 mg</arm_group_label>
    <arm_group_label>TRAPS: 150 mg</arm_group_label>
    <other_name>ACZ885</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebo to canakinumab solution for subcutaneous injection</description>
    <arm_group_label>crCMF: placebo</arm_group_label>
    <arm_group_label>HIDS/MKD: placebo</arm_group_label>
    <arm_group_label>TRAPS: placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: - Patient's written informed consent (or parent's written informed
        consent in case of pediatric patient) at screening - Male and female patients at least 2
        years of age at the time of the screening visit. Male and female patients &gt;28 days but &lt;2
        years eligible for open label treatment only. - Confirmed diagnosis and active flare at
        randomization - CRP &gt;10mg/L at randomization

        Exclusion Criteria: - Use of the following therapies (within varying protocol defined
        timeframes): Corticosteroids, anakinra, canakinumab, rilonacept, tocilizumab, TNF
        inhibitors, abatacept, tofacitinib, rituximab, leflunomide, thalidomide, cyclosporine,
        intravenous immunoglobulin, 6-Merceptopurine, azathioprine, cyclophosphamide, or
        chlorambucil, any other investigational biologics - History of malignancy of any organ
        system (other than localized basal cell carcinoma of the skin or in - situ cervical
        cancer), treated or untreated - Significant medical diseases, including but not limited to
        the following: a. History of organ transplantation b. Elevated liver enzymes ≥3x ULN d.
        Increase in total bilirubin e. Serious hepatic disorder (Child-Pugh scores B or C) f.
        Chronic Kidney Disease g. Thyroid disease h. Diagnosis of active peptic ulcer disease i.
        Coagulopathy j. Significant CNS effects including vertigo and dizziness - Any conditions or
        significant medical problems which immunecompromise the patient and/or places the patient
        at unacceptable risk for immunomodulatory therapy - Live vaccinations within 3 months prior
        to the start of the trial, during the trial, and up to 3 months following the last dose
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Pharmaceuticals</last_name>
    <role>Study Director</role>
    <affiliation>Novartis Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Edegem</city>
        <state>Antwerpen</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hasselt</city>
        <zip>3500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3B 6A8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bron Cedex</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Le Kremlin Bicetre</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nimes Cedex</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Germering</city>
        <zip>82110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamburg</city>
        <zip>22081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Muenchen</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Augustin</city>
        <zip>53757</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Budapest</city>
        <zip>1023</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Budapest</city>
        <zip>1094</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Galway</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Haifa</city>
        <zip>3339419</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Haifa</city>
        <zip>3525408</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jerusalem</city>
        <zip>9103102</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Petach-Tikva</city>
        <zip>49202</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ramat Gan</city>
        <zip>5266202</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sciacca</city>
        <state>AG</state>
        <zip>92019</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brescia</city>
        <state>BS</state>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Firenze</city>
        <state>FI</state>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Genova</city>
        <state>GE</state>
        <zip>16147</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Messina</city>
        <state>ME</state>
        <zip>98125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00165</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trieste</city>
        <state>TS</state>
        <zip>34137</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fukuoka city</city>
        <state>Fukuoka</state>
        <zip>812-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yokohama-city</city>
        <state>Kanagawa</state>
        <zip>236-0004</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sakyo-ku</city>
        <state>Kyoto</state>
        <zip>606 8507</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Niigata</city>
        <zip>951-8520</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nijmegen</city>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Utrecht</city>
        <zip>3508 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>115522</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>117198</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>119991</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rostov on Don</city>
        <zip>344022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>194100</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Esplugues de Llobregat</city>
        <state>Barcelona</state>
        <zip>08950</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barcelona</city>
        <state>Catalunya</state>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Valencia</city>
        <state>Comunidad Valenciana</state>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Istanbul</city>
        <state>TUR</state>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>London</city>
        <zip>WC1N 1EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Ireland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Greece</country>
  </removed_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2014</study_first_submitted>
  <study_first_submitted_qc>February 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2014</study_first_posted>
  <results_first_submitted>November 21, 2016</results_first_submitted>
  <results_first_submitted_qc>January 26, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 17, 2017</results_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Canakinumab, interleukin-1, Hereditary Periodic Fevers, auto-inflammatory diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
    <mesh_term>Familial Mediterranean Fever</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Hereditary Autoinflammatory Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies, Monoclonal</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This study consists of 4 study epochs. A total of 203 participants ((181randomized + 4 non-randomized open-label participants in Epoch 2) + (18 TRAPS rollover participants from ACZ885D2203 (NCT01242813) and ACZ885D2207M in Epoch 3)) have been enrolled into this study.</recruitment_details>
      <pre_assignment_details>126 patients, randomized in Epoch 2, were not re-randomized in Epoch 3. These patients were switched to open-label (OL) treatment. Six patients discontinued OL treatment (1 due to physician decision, 1 due to subject/guardian decision, 3 due to lack of efficacy and 1 due to an adverse event).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Epoch 2: crFMF: 150 mg</title>
          <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
        </group>
        <group group_id="P2">
          <title>Epoch 2: crCMF: Placebo</title>
          <description>During epoch 2, participants received matching placebo to canakinumab 150 mg Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab.
150mg, participants were uptitrated to open-label canakinumab 300 mg</description>
        </group>
        <group group_id="P3">
          <title>Epoch 2: HIDS/MKD: 150 mg</title>
          <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
        </group>
        <group group_id="P4">
          <title>Epoch 2: HIDS/MKD: Placebo</title>
          <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
        </group>
        <group group_id="P5">
          <title>Epoch 2: TRAPS: 150 mg</title>
          <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration</description>
        </group>
        <group group_id="P6">
          <title>Epoch 2: TRAPS: Placebo</title>
          <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between Day 8 and 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
        </group>
        <group group_id="P7">
          <title>Epoch 2: Non-randomized Open Label Treatment - crFMF</title>
          <description>Canakinumab-naïve Japanese patients with non-exon 10 mutations received open-label canakinumab 150 mg (or 2 mg/kg for patients weighing
≤ 40 kg) q4w .</description>
        </group>
        <group group_id="P8">
          <title>Epoch 2: Non-randomized Open Label HIDS/MKD</title>
          <description>Participants in the 28 days to less than 2 years old cohort who received open-label canakinumab 150 mg (or 2mg/kg for patients weighing
≤ 40 kg) q4w.</description>
        </group>
        <group group_id="P9">
          <title>Epoch 2 (Epoch 3) - Non-randomized Open Label TRAPS</title>
          <description>Open-label treatment in Epoch 3 was initiated for TRAPS patients who rolled over from CACZ885D2203 or CACZ885D2207M.</description>
        </group>
        <group group_id="P10">
          <title>Epoch 3: crFMF Re-randomized From Epoch 2 - 150 mg</title>
          <description>Canakinumab responders who were initially randomized to canakinumab 150 mg q4w and did not re-flare in Epoch 2 were re-randomized at the start of Epoch 3 to canakinumab 150 mg q8w for 24 weeks.</description>
        </group>
        <group group_id="P11">
          <title>Epoch 3: crFMF Re-randomized From Epoch 2 - Placebo</title>
          <description>Canakinumab responders who were initially randomized to canakinumab 150 mg q4w and did not re-flare in Epoch 2 were re-randomized at the start of Epoch 3 to placebo for 24 weeks.</description>
        </group>
        <group group_id="P12">
          <title>Epoch 3: HIDs/MKD Re-randomized From Epoch 2 - 150 mg</title>
          <description>Canakinumab responders who were initially randomized to canakinumab 150 mg q4w and did not re-flare in Epoch 2 were re-randomized at the start of Epoch 3 to canakinumab 150 mg q8w for 24 weeks.</description>
        </group>
        <group group_id="P13">
          <title>Epoch 3: HIDS/MKD Re-randomized From Epoch 2 - Placebo</title>
          <description>Canakinumab responders who were initially randomized to canakinumab 150 mg q4w and did not re-flare in Epoch 2 were re-randomized at the start of Epoch 3 to placebo for 24 weeks.</description>
        </group>
        <group group_id="P14">
          <title>Epoch 3: TRAPS Re-randomized From Epoch 2 - 150 mg</title>
          <description>Canakinumab responders who were initially randomized to canakinumab 150 mg q4w and did not re-flare in Epoch 2 were re-randomized at the start of Epoch 3 to canakinumab 150 mg q8w for 24 weeks.</description>
        </group>
        <group group_id="P15">
          <title>Epoch 3: TRAPS Re-randomized From Epoch 2 - Placebo</title>
          <description>Canakinumab responders who were initially randomized to canakinumab 150 mg q4w and did not re-flare in Epoch 2 were re-randomized at the start of Epoch 3 to placebo for 24 weeks.</description>
        </group>
        <group group_id="P16">
          <title>Epoch 3: crFMF, HIDS/MKD, TRAPS - Not Re-randomized</title>
          <description>All Epoch 2 non-responders were switched to canakinumab q8w at the start of Epoch 3 for 24 weeks,</description>
        </group>
        <group group_id="P17">
          <title>Epoch 4: crFMF - Open Label Cumulative Dose &lt;2700 mg</title>
          <description>During epoch 4, participants received open label treatment according to the dose regimen administered in epoch 3. Cumulative dose received was less than 2700 mg.</description>
        </group>
        <group group_id="P18">
          <title>Epoch 4: crFMF - Open Label Cumulative Dose 2700 mg - &lt;5400 mg</title>
          <description>During epoch 4, participants received open label treatment according to the dose regimen administered in epoch 3. Cumulative dose received was &gt;= 2700 mg and &lt; 5400 mg.</description>
        </group>
        <group group_id="P19">
          <title>Epoch 4: crFMF - Open Label Cumulative Dose &gt;=5400 mg</title>
          <description>During epoch 4, participants received open label treatment according to the dose regimen administered in epoch 3. Cumulative dose received was &gt; 5400 mg.</description>
        </group>
        <group group_id="P20">
          <title>Epoch 4: HIDS/MKD - Open Label Cumulative Dose &lt;2700 mg</title>
          <description>During epoch 4, participants received open label treatment according to the dose regimen administered in epoch 3. Cumulative dose received was less than 2700 mg.</description>
        </group>
        <group group_id="P21">
          <title>Epoch 4: HIDS/MKD - OL Cumulative Dose 2700 - &lt;=5400 mg</title>
          <description>During epoch 4, participants received open label treatment according to the dose regimen administered in epoch 3. Cumulative dose received was &gt;= 2700 mg and &lt; 5400 mg.</description>
        </group>
        <group group_id="P22">
          <title>Epoch 4: HIDS/MKD - Open Label Cumulative Dose &gt;=5400 mg</title>
          <description>During epoch 4, participants received open label treatment according to the dose regimen administered in epoch 3. Cumulative dose received was &gt; 5400 mg.</description>
        </group>
        <group group_id="P23">
          <title>Epoch 4: TRAPS - Open Label Cumulative Dose &lt; 2700 mg</title>
          <description>During epoch 4, participants received open label treatment according to the dose regimen administered in epoch 3. Cumulative dose received was less than 2700 mg.</description>
        </group>
        <group group_id="P24">
          <title>Epoch 4: TRAPS - Open Label Cumulative Dose 2700 - &lt;5400 mg</title>
          <description>During epoch 4, participants received open label treatment according to the dose regimen administered in epoch 3. Cumulative dose received was &gt;= 2700 mg and &lt; 5400 mg.</description>
        </group>
        <group group_id="P25">
          <title>Epoch 4: TRAPS - Open Label Cumulative Dose &gt;=5400 mg</title>
          <description>During epoch 4, participants received open label treatment according to the dose regimen administered in epoch 3. Cumulative dose received was &gt; 5400 mg.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Epoch 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="37"/>
                <participants group_id="P4" count="35"/>
                <participants group_id="P5" count="22"/>
                <participants group_id="P6" count="24"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="18">This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.</participants>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="31"/>
                <participants group_id="P3" count="36"/>
                <participants group_id="P4" count="33"/>
                <participants group_id="P5" count="22"/>
                <participants group_id="P6" count="22"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="16"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="2"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Epoch 3</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0">Presented in Epoch 2.</participants>
                <participants group_id="P10" count="9"/>
                <participants group_id="P11" count="10"/>
                <participants group_id="P12" count="6"/>
                <participants group_id="P13" count="7"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="5"/>
                <participants group_id="P16" count="126"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="9"/>
                <participants group_id="P11" count="10"/>
                <participants group_id="P12" count="6"/>
                <participants group_id="P13" count="7"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="5"/>
                <participants group_id="P16" count="120"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="6"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="3"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Epoch 4</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="43"/>
                <participants group_id="P18" count="14"/>
                <participants group_id="P19" count="2"/>
                <participants group_id="P20" count="18"/>
                <participants group_id="P21" count="34"/>
                <participants group_id="P22" count="14"/>
                <participants group_id="P23" count="31"/>
                <participants group_id="P24" count="22"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="41"/>
                <participants group_id="P18" count="14"/>
                <participants group_id="P19" count="2"/>
                <participants group_id="P20" count="18"/>
                <participants group_id="P21" count="33"/>
                <participants group_id="P22" count="14"/>
                <participants group_id="P23" count="30"/>
                <participants group_id="P24" count="21"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="1"/>
                <participants group_id="P24" count="1"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="1"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="1"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="1"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="1"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Epoch 2: crFMF: 150 mg</title>
          <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
        </group>
        <group group_id="B2">
          <title>Epoch 2: crCMF: Placebo</title>
          <description>During epoch 2, participants received matching placebo to canakinumab 150 mg Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab.
150mg, participants were uptitrated to open-label canakinumab 300 mg</description>
        </group>
        <group group_id="B3">
          <title>Epoch 2: HIDS/MKD: 150 mg</title>
          <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
        </group>
        <group group_id="B4">
          <title>Epoch 2: HIDS/MKD: Placebo</title>
          <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
        </group>
        <group group_id="B5">
          <title>Epoch 2: TRAPS: 150 mg</title>
          <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration</description>
        </group>
        <group group_id="B6">
          <title>Epoch 2: TRAPS: Placebo</title>
          <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between Day 8 and 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
        </group>
        <group group_id="B7">
          <title>Epoch 2: Non-randomized Open Label Treatment - crFMF</title>
          <description>Canakinumab-naïve Japanese patients with non-exon 10 mutations received open-label canakinumab 150 mg (or 2 mg/kg for patients weighing
≤ 40 kg) q4w</description>
        </group>
        <group group_id="B8">
          <title>Epoch 2: Non-randomized Open Label HIDS/MKD</title>
          <description>Participants in the 28 days to less than 2 years old cohort who received open-label canakinumab 150 mg (or 2mg/kg for patients weighing
≤ 40 kg) q4w.</description>
        </group>
        <group group_id="B9">
          <title>Epoch 2 (Epoch 3) - Non-randomized Open Label TRAPS</title>
          <description>Open-label treatment in Epoch 3 was initiated for TRAPS patients who rolled over from CACZ885D2203 or CACZ885D2207M.</description>
        </group>
        <group group_id="B10">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="37"/>
            <count group_id="B4" value="35"/>
            <count group_id="B5" value="22"/>
            <count group_id="B6" value="24"/>
            <count group_id="B7" value="2"/>
            <count group_id="B8" value="2"/>
            <count group_id="B9" value="18"/>
            <count group_id="B10" value="203"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <title>crFMF cohort - randomized</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18.0" spread="15.02" lower_limit="2" upper_limit="60"/>
                    <measurement group_id="B2" value="18.0" spread="13.38" lower_limit="4" upper_limit="69"/>
                    <measurement group_id="B3" value="NA">This row reflects crFMF cohort - randomized data only.</measurement>
                    <measurement group_id="B4" value="NA">This row reflects crFMF cohort - randomized data only.</measurement>
                    <measurement group_id="B5" value="NA">This row reflects crFMF cohort - randomized data only.</measurement>
                    <measurement group_id="B6" value="NA">This row reflects crFMF cohort - randomized data only.</measurement>
                    <measurement group_id="B7" value="NA">This row reflects crFMF cohort - randomized data only.</measurement>
                    <measurement group_id="B8" value="NA">This row reflects crFMF cohort - randomized data only.</measurement>
                    <measurement group_id="B9" value="NA">This row reflects crFMF cohort - randomized data only.</measurement>
                    <measurement group_id="B10" value="18" spread="14.10" lower_limit="2" upper_limit="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIDS/MKD cohort - randomized</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">This row reflect HIDS/MKD cohort - randomized data only.</measurement>
                    <measurement group_id="B2" value="NA">This row reflect HIDS/MKD cohort - randomized data only.</measurement>
                    <measurement group_id="B3" value="12.0" spread="8.49" lower_limit="2" upper_limit="43"/>
                    <measurement group_id="B4" value="9.0" spread="11.64" lower_limit="3" upper_limit="47"/>
                    <measurement group_id="B5" value="NA">This row reflect HIDS/MKD cohort - randomized data only.</measurement>
                    <measurement group_id="B6" value="NA">This row reflect HIDS/MKD cohort - randomized data only.</measurement>
                    <measurement group_id="B7" value="NA">This row reflect HIDS/MKD cohort - randomized data only.</measurement>
                    <measurement group_id="B8" value="NA">This row reflect HIDS/MKD cohort - randomized data only.</measurement>
                    <measurement group_id="B9" value="NA">This row reflect HIDS/MKD cohort - randomized data only.</measurement>
                    <measurement group_id="B10" value="11.0" spread="10.08" lower_limit="2" upper_limit="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TRAPS cohort - randomized</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">This row reflect TRAPS cohort - randomized data only.</measurement>
                    <measurement group_id="B2" value="NA">This row reflect TRAPS cohort - randomized data only.</measurement>
                    <measurement group_id="B3" value="NA">This row reflect TRAPS cohort - randomized data only.</measurement>
                    <measurement group_id="B4" value="NA">This row reflect TRAPS cohort - randomized data only.</measurement>
                    <measurement group_id="B5" value="13.5" spread="19.22" lower_limit="3" upper_limit="76"/>
                    <measurement group_id="B6" value="16.5" spread="18.25" lower_limit="2" upper_limit="57"/>
                    <measurement group_id="B7" value="NA">This row reflect TRAPS cohort - randomized data only.</measurement>
                    <measurement group_id="B8" value="NA">This row reflect TRAPS cohort - randomized data only.</measurement>
                    <measurement group_id="B9" value="NA">This row reflect TRAPS cohort - randomized data only.</measurement>
                    <measurement group_id="B10" value="15.5" spread="18.55" lower_limit="2" upper_limit="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>crFMF - non-randomized</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">This row reflects crFMF non-randomized data only.</measurement>
                    <measurement group_id="B2" value="NA">This row reflects crFMF non-randomized data only.</measurement>
                    <measurement group_id="B3" value="NA">This row reflects crFMF non-randomized data only.</measurement>
                    <measurement group_id="B4" value="NA">This row reflects crFMF non-randomized data only.</measurement>
                    <measurement group_id="B5" value="NA">This row reflects crFMF non-randomized data only.</measurement>
                    <measurement group_id="B6" value="NA">This row reflects crFMF non-randomized data only.</measurement>
                    <measurement group_id="B7" value="24.5" lower_limit="20" upper_limit="29"/>
                    <measurement group_id="B8" value="NA">This row reflects crFMF non-randomized data only.</measurement>
                    <measurement group_id="B9" value="NA">This row reflects crFMF non-randomized data only.</measurement>
                    <measurement group_id="B10" value="24.5" lower_limit="20" upper_limit="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIDS/MKD - non-randomized</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">This row reflects HIDS/MIK non-randomized data only.</measurement>
                    <measurement group_id="B2" value="NA">This row reflects HIDS/MIK non-randomized data only.</measurement>
                    <measurement group_id="B3" value="NA">This row reflects HIDS/MIK non-randomized data only.</measurement>
                    <measurement group_id="B4" value="NA">This row reflects HIDS/MIK non-randomized data only.</measurement>
                    <measurement group_id="B5" value="NA">This row reflects HIDS/MIK non-randomized data only.</measurement>
                    <measurement group_id="B6" value="NA">This row reflects HIDS/MIK non-randomized data only.</measurement>
                    <measurement group_id="B7" value="NA">This row reflects HIDS/MIK non-randomized data only.</measurement>
                    <measurement group_id="B8" value="1.0" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="B9" value="NA">This row reflects HIDS/MIK non-randomized data only.</measurement>
                    <measurement group_id="B10" value="1.0" lower_limit="1" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>roll-over TRAPS - non-randomized</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">This row reflects roll-over TRAPS non-randomized data only.</measurement>
                    <measurement group_id="B2" value="NA">This row reflects roll-over TRAPS non-randomized data only.</measurement>
                    <measurement group_id="B3" value="NA">This row reflects roll-over TRAPS non-randomized data only.</measurement>
                    <measurement group_id="B4" value="NA">This row reflects roll-over TRAPS non-randomized data only.</measurement>
                    <measurement group_id="B5" value="NA">This row reflects roll-over TRAPS non-randomized data only.</measurement>
                    <measurement group_id="B6" value="NA">This row reflects roll-over TRAPS non-randomized data only.</measurement>
                    <measurement group_id="B7" value="NA">This row reflects roll-over TRAPS non-randomized data only.</measurement>
                    <measurement group_id="B8" value="NA">This row reflects roll-over TRAPS non-randomized data only.</measurement>
                    <measurement group_id="B9" value="42.5" lower_limit="15" upper_limit="81"/>
                    <measurement group_id="B10" value="42.5" lower_limit="15" upper_limit="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="19"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="13"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="7"/>
                    <measurement group_id="B10" value="104"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="11"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="11"/>
                    <measurement group_id="B10" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="31"/>
                    <measurement group_id="B5" value="20"/>
                    <measurement group_id="B6" value="18"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="16"/>
                    <measurement group_id="B10" value="174"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Resolution of Initial Flare and Absence of New Flares up to the End of the Randomized Treatment Epoch (16 Weeks)</title>
        <description>Resolution of the initial disease flare is defined as: Physician's Global Assessment of Disease activity (PGA) &lt;2 and C-reactive protein (CRP) within normal range (&lt;= 10 mg/L) or reduction by at least 70% from baseline. The PGA was evaluated by the investigator based on a 5-point scale: 0 = None (no) disease associated with clinical signs and symptoms; 1 = minimal disease associated signs and symptoms; 2 = mild disease associated signs and symptoms; 3 = moderate disease associated signs and symptoms; and 5 = severe disease associated signs and symptoms.</description>
        <time_frame>16 weeks</time_frame>
        <population>The Full Analysis Set (FAS), which consisted of all randomized participants in the randomized treatment epoch who received at least one dose of study drug in Epoch 2, was analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Epoch 2: crFMF: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O2">
            <title>Epoch 2: crCMF: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab.
150mg, participants were uptitrated to open-label canakinumab 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Epoch 2: HIDS/MKD: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O4">
            <title>Epoch 2: HIDS/MKD: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
          <group group_id="O5">
            <title>Epoch 2: TRAPS: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration</description>
          </group>
          <group group_id="O6">
            <title>Epoch 2: TRAPS: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between Day 8 and 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Resolution of Initial Flare and Absence of New Flares up to the End of the Randomized Treatment Epoch (16 Weeks)</title>
          <description>Resolution of the initial disease flare is defined as: Physician's Global Assessment of Disease activity (PGA) &lt;2 and C-reactive protein (CRP) within normal range (&lt;= 10 mg/L) or reduction by at least 70% from baseline. The PGA was evaluated by the investigator based on a 5-point scale: 0 = None (no) disease associated with clinical signs and symptoms; 1 = minimal disease associated signs and symptoms; 2 = mild disease associated signs and symptoms; 3 = moderate disease associated signs and symptoms; and 5 = severe disease associated signs and symptoms.</description>
          <population>The Full Analysis Set (FAS), which consisted of all randomized participants in the randomized treatment epoch who received at least one dose of study drug in Epoch 2, was analyzed.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="35"/>
                <count group_id="O5" value="22"/>
                <count group_id="O6" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.29"/>
                    <measurement group_id="O2" value="6.25"/>
                    <measurement group_id="O3" value="35.14"/>
                    <measurement group_id="O4" value="5.71"/>
                    <measurement group_id="O5" value="45.45"/>
                    <measurement group_id="O6" value="8.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Fisher's exact test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0020</p_value>
            <method>Fisher's exact test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0050</p_value>
            <method>Fisher's exact test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Achieve Physician's Global Assessment (PGA) &lt; 2</title>
        <description>The PGA was evaluated by the investigator based on a 5-point scale: 0 = None (no) disease associated with clinical signs and symptoms; 1 = minimal disease associated signs and symptoms; 2 = mild disease associated signs and symptoms; 3 = moderate disease associated signs and symptoms; and 5 = severe disease associated signs and symptoms.</description>
        <time_frame>16 weeks</time_frame>
        <population>The Full Analysis Set (FAS), which consisted of all randomized participants in the randomized treatment epoch who received at least one dose of study drug in Epoch 2, was analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Epoch 2: crFMF: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O2">
            <title>Epoch 2: crCMF: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab.
150mg, participants were uptitrated to open-label canakinumab 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Epoch 2: HIDS/MKD: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O4">
            <title>Epoch 2: HIDS/MKD: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
          <group group_id="O5">
            <title>Epoch 2: TRAPS: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration</description>
          </group>
          <group group_id="O6">
            <title>Epoch 2: TRAPS: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between Day 8 and 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Achieve Physician's Global Assessment (PGA) &lt; 2</title>
          <description>The PGA was evaluated by the investigator based on a 5-point scale: 0 = None (no) disease associated with clinical signs and symptoms; 1 = minimal disease associated signs and symptoms; 2 = mild disease associated signs and symptoms; 3 = moderate disease associated signs and symptoms; and 5 = severe disease associated signs and symptoms.</description>
          <population>The Full Analysis Set (FAS), which consisted of all randomized participants in the randomized treatment epoch who received at least one dose of study drug in Epoch 2, was analyzed.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="35"/>
                <count group_id="O5" value="22"/>
                <count group_id="O6" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.52"/>
                    <measurement group_id="O2" value="9.38"/>
                    <measurement group_id="O3" value="45.95"/>
                    <measurement group_id="O4" value="5.71"/>
                    <measurement group_id="O5" value="45.45"/>
                    <measurement group_id="O6" value="4.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>16.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.15</ci_lower_limit>
            <ci_upper_limit>69.21</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0006</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>13.63</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.83</ci_lower_limit>
            <ci_upper_limit>65.59</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0028</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>23.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.52</ci_lower_limit>
            <ci_upper_limit>224.86</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With the Serologic Remission</title>
        <description>Serologic remission was defined as C-reactive protein &lt;= 10 mg/L.</description>
        <time_frame>16 weeks</time_frame>
        <population>The Full Analysis Set (FAS), which consisted of all randomized participants in the randomized treatment epoch who received at least one dose of study drug in Epoch 2, was analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Epoch 2: crFMF: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O2">
            <title>Epoch 2: crCMF: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab.
150mg, participants were uptitrated to open-label canakinumab 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Epoch 2: HIDS/MKD: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O4">
            <title>Epoch 2: HIDS/MKD: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
          <group group_id="O5">
            <title>Epoch 2: TRAPS: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration</description>
          </group>
          <group group_id="O6">
            <title>Epoch 2: TRAPS: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between Day 8 and 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With the Serologic Remission</title>
          <description>Serologic remission was defined as C-reactive protein &lt;= 10 mg/L.</description>
          <population>The Full Analysis Set (FAS), which consisted of all randomized participants in the randomized treatment epoch who received at least one dose of study drug in Epoch 2, was analyzed.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="35"/>
                <count group_id="O5" value="22"/>
                <count group_id="O6" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.74"/>
                    <measurement group_id="O2" value="6.25"/>
                    <measurement group_id="O3" value="40.54"/>
                    <measurement group_id="O4" value="5.71"/>
                    <measurement group_id="O5" value="36.36"/>
                    <measurement group_id="O6" value="8.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>29.78</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>5.86</ci_lower_limit>
            <ci_upper_limit>151.31</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0010</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>12.71</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.53</ci_lower_limit>
            <ci_upper_limit>63.89</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0149</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>6.64</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.20</ci_lower_limit>
            <ci_upper_limit>36.57</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Normalized Serum Amyloid A (SAA) Level</title>
        <description>Normalized SAA was defined as SAA &lt;= 10 mg/L.</description>
        <time_frame>16 weeks</time_frame>
        <population>The Full Analysis Set (FAS), which consisted of all randomized participants in the randomized treatment epoch who received at least one dose of study drug in Epoch 2, was analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Epoch 2: crFMF: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O2">
            <title>Epoch 2: crCMF: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab.
150mg, participants were uptitrated to open-label canakinumab 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Epoch 2: HIDS/MKD: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O4">
            <title>Epoch 2: HIDS/MKD: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
          <group group_id="O5">
            <title>Epoch 2: TRAPS: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration</description>
          </group>
          <group group_id="O6">
            <title>Epoch 2: TRAPS: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between Day 8 and 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Normalized Serum Amyloid A (SAA) Level</title>
          <description>Normalized SAA was defined as SAA &lt;= 10 mg/L.</description>
          <population>The Full Analysis Set (FAS), which consisted of all randomized participants in the randomized treatment epoch who received at least one dose of study drug in Epoch 2, was analyzed.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="35"/>
                <count group_id="O5" value="22"/>
                <count group_id="O6" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.81"/>
                    <measurement group_id="O2" value="0.00"/>
                    <measurement group_id="O3" value="13.51"/>
                    <measurement group_id="O4" value="2.86"/>
                    <measurement group_id="O5" value="27.27"/>
                    <measurement group_id="O6" value="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0286</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>17.46</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.92</ci_lower_limit>
            <ci_upper_limit>332.92</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0778</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>5.26</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.53</ci_lower_limit>
            <ci_upper_limit>51.97</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0235</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>16.69</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.04</ci_lower_limit>
            <ci_upper_limit>268.50</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants of Canakinumab Responders From Epoch 2 Who Maintained a Clinically Meaningful Response (Absence of New Flares) (40 Weeks)</title>
        <description>A responder was defined as a participant who had no flare between week 16 and week 40.</description>
        <time_frame>40 weeks</time_frame>
        <population>The re-randomized set was analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Epoch 2: crFMF: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O2">
            <title>Epoch 2: crCMF: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab.
150mg, participants were uptitrated to open-label canakinumab 300 mg</description>
          </group>
          <group group_id="O3">
            <title>Epoch 2: HIDS/MKD: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration.</description>
          </group>
          <group group_id="O4">
            <title>Epoch 2: HIDS/MKD: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
          <group group_id="O5">
            <title>Epoch 2: TRAPS: 150 mg</title>
            <description>During Epoch 2, participants received canakinumab 150mg (or 2mg/kg for participants weighing &lt;= 40kg) q4w for 16 weeks. If participants were eligible for blinded escape, they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between day 8 and day 28, and then received blinded uptitration to canakinumab 300 mg q4w from day 29 through day 112. If patients on the highest allowed canakinumab dose of 300 mg (or 4 mg/kg for patients weighing ≤ 40 kg) q4w and re-flared (PGA ≥ 2 and CRP ≥ 30 mg/L) were not eligible for further up-titration</description>
          </group>
          <group group_id="O6">
            <title>Epoch 2: TRAPS: Placebo</title>
            <description>During epoch 2, participants received matching placebo to canakinumab 150 mg qw4. Participants who required blinded escape,they received a single add-on dose of canakinumab (150 mg or 2mg/kg for participants weighing &lt;= 40kg) between Day 8 and 28 and then received blinded one dose of placebo and one dose of canakinumab q4w from day 29 through day 112. If flare or re-flare still occurred after receipt of canakinumab 150mg, participants were uptitrated to open-label canakinumab 300 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants of Canakinumab Responders From Epoch 2 Who Maintained a Clinically Meaningful Response (Absence of New Flares) (40 Weeks)</title>
          <description>A responder was defined as a participant who had no flare between week 16 and week 40.</description>
          <population>The re-randomized set was analyzed.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="6"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.8"/>
                    <measurement group_id="O2" value="30.0"/>
                    <measurement group_id="O3" value="50.0"/>
                    <measurement group_id="O4" value="14.3"/>
                    <measurement group_id="O5" value="75.0"/>
                    <measurement group_id="O6" value="40.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0513</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>8.17</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.75</ci_lower_limit>
            <ci_upper_limit>113.44</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2168</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>6.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.27</ci_lower_limit>
            <ci_upper_limit>366.24</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3571</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>4.50</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.15</ci_lower_limit>
            <ci_upper_limit>313.49</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>up to week 112</time_frame>
      <desc>Cohort groups were analyzed according to the occurrence of events corresponding to treatments given during epochs 2, 3 and 4.
'No medication' events cover events that occurred during epoch 4 when no treatment was given.</desc>
      <group_list>
        <group group_id="E1">
          <title>Non-randomized Open Label crFMF, HIDS/MKD Patients</title>
          <description>Canakinumab-naïve Japanese patients with non-exon 10 mutations with cr-FMF who received open-label canakinumab 150 mg (or 2 mg/kg for patients weighing ≤ 40 kg) q4w; and patients in the 28 days to less than 2 years old cohort with HIDS/MKD who received open-label canakinumab 150 mg (or 2mg/kg for patients weighing
≤ 40 kg) q4w</description>
        </group>
        <group group_id="E2">
          <title>Non-randomized Open Label TRAPS Patients</title>
          <description>Open-label treatment in Epoch 3 was initiated for TRAPS patients who rolled over from CACZ885D2203 or CACZ885D2207M</description>
        </group>
        <group group_id="E3">
          <title>Randomized ACZ and Placebo TRAPS Patients – Placebo Events</title>
          <description>Patients who received ACZ885 and/or placebo during epoch 2 and/or epoch 3.</description>
        </group>
        <group group_id="E4">
          <title>Randomized ACZ and Placebo TRAPS Pts - No Medication Events</title>
          <description>Patients who received ACZ885 and/or placebo during epoch 2 and/or epoch 3 .</description>
        </group>
        <group group_id="E5">
          <title>Randomized ACZ and Placebo TRAPS Patients - ACZ Events</title>
          <description>Patients who received ACZ885 and/or placebo during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E6">
          <title>Randomized ACZ and Placebo HIDS/MKD Pts - Placebo Events</title>
          <description>Patients who received ACZ885 and/or placebo during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E7">
          <title>Randomized ACZ and Placebo HIDS/MKD Pts - No Medication Events</title>
          <description>Patients who received ACZ885 and/or placebo during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E8">
          <title>Randomized ACZ and Placebo HIDS/MKD Patients - ACZ Events</title>
          <description>Patients who received ACZ885 and/or placebo during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E9">
          <title>Randomized ACZ and Placebo crFMF Patients - Placebo Events</title>
          <description>Patients who received ACZ885 and/or placebo during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E10">
          <title>Randomized ACZ and Placebo crFMF Pts - No Medication Events</title>
          <description>Patients who received ACZ885 and/or placebo during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E11">
          <title>Randomized ACZ and Placebo crFMF Patients - ACZ Events</title>
          <description>Patients who received ACZ885 and/or placebo during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E12">
          <title>Any ACZ TRAPS Patients - Placebo Events</title>
          <description>Patients who received ACZ885 during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E13">
          <title>Any ACZ TRAPS Patients - no Medication Events</title>
          <description>Patients who received ACZ885 during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E14">
          <title>Any ACZ TRAPS Patients - ACZ Events</title>
          <description>Patients who received ACZ885 during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E15">
          <title>Any ACZ HIDS/MKD Patients - Placebo Events</title>
          <description>Patients who received ACZ885 during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E16">
          <title>Any ACZ HIDS/MKD Patients - No Medication Events</title>
          <description>Patients who received ACZ885 during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E17">
          <title>Any ACZ HIDS/MKD Patients - ACZ Events</title>
          <description>Patients who received ACZ885 during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E18">
          <title>Any ACZ crFMF Patients - Placebo Events</title>
          <description>Patients who received ACZ885 during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E19">
          <title>Any ACZ crFMF Patients - No Medication Events</title>
          <description>Patients who received ACZ885 during epoch 2 and/or epoch 3</description>
        </group>
        <group group_id="E20">
          <title>Any ACZ crFMF Patients - ACZ Events</title>
          <description>Patients who received ACZ885 during epoch 2 and/or epoch 3</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (20.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="16" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="16" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="9" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="18" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="17" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Familial mediterranean fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Hyper IgD syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Tumour necrosis factor receptor-associated periodic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Thyroiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Ileal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperpyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Polyserositis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Granulomatous liver disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Atypical pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Gastroenteritis rotavirus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Herpes virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Infectious colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pelvic abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pharyngotonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Vulval abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Scar</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Schizophrenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Laryngeal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Vocal cord polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Granulomatous rosacea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pyoderma gangrenosum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (20.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="43" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="25" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="68" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="29" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="54" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="61" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="7" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="70" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="10" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="56" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="18" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="18" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="5" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Familial mediterranean fever</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="15" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="19" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="5" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="20" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Hyper IgD syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="19" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="20" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Tumour necrosis factor receptor-associated periodic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="10" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye allergy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Scleritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="25" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="16" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="18" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="25" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="16" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="14" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="14" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="6" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Aphthous ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="16" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="17" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="5" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="22" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="12" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="12" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="23" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="13" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Gastric dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="8" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="6" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Teething</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="12" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="12" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="6" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="6" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="6" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="6" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="9" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="11" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="9" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="11" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="7" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="7" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="39" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="13" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="19" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="40" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="13" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="11" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="8" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="11" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="9" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="14" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="14" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="11" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="9" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="9" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Otitis media acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="7" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="8" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pharyngotonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="8" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="14" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="15" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="8" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Tonsillitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Tracheitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="22" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="12" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="13" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="22" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="12" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="9" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="9" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="7" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="6" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Viral tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="20" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="7" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="16" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="20" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="8" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Vulvovaginal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="6" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>C-reactive protein increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Eosinophil count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Glomerular filtration rate decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Neutrophil count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Neutrophil count increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Serum amyloid A protein increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="18" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="11" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="11" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="18" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="12" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="13" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="10" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="14" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="4" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="6" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="4" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="7" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="7" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="7" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="7" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="9" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Tendon pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Tenosynovitis stenosans</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Pyogenic granuloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="4" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="30" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="16" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="14" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="31" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="16" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Polycystic ovaries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="21" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="12" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="21" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="6" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="6" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="22" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="22" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="8" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="7" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="7" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="5" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Keloid scar</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pain of skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Pyoderma gangrenosum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="61"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Novartic Pharmaceuticals</organization>
      <phone>862-778-8300</phone>
      <email>novartis.email@novartis.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

